Immunoprecise Antibodies Correlations

IPA
 Stock
  

USD 3.84  0.04  1.05%   

The correlation of Immunoprecise Antibodies is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immunoprecise Antibodies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immunoprecise Antibodies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Please see Risk vs Return Analysis.
  
Refresh
The ability to find closely correlated positions to Immunoprecise Antibodies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immunoprecise Antibodies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immunoprecise Antibodies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immunoprecise Antibodies to buy it.

Moving together with Immunoprecise Antibodies

0.8AADIAadi BiosciencesPairCorr
0.63ABCMAbcam Plc ADRPairCorr
0.65ABSIAbsci CorpPairCorr
0.71ABTIAlterola BiotechPairCorr
0.76ABVCAbvc BiopharmaPairCorr
0.7ACERAcer TherapeuticsPairCorr
0.84ACHVAchieve Life SciencesPairCorr
0.62ACORAcorda TherapeuticsPairCorr

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
FUBER
UBERMSFT
FMSFT
CRMMSFT
JPMA
JPMF
  
High negative correlations   

Immunoprecise Antibodies Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Immunoprecise Antibodies stock performing well and Immunoprecise Antibodies company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Immunoprecise Antibodies' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR 2.81  0.10  0.05 (0.01)  3.51  0.04 (2.99)  5.66 (5.40)  36.79 
MSFT 1.92  0.00  0.00 (0.19)  0.00 (0.0357)  0.00  2.97 (4.24)  9.36 
UBER 3.35 (0.41)  0.00 (0.42)  0.00 (0.14)  0.00  6.32 (7.19)  18.56 
F 2.40 (0.33)  0.00 (0.40)  0.00 (0.15)  0.00  3.68 (5.54)  16.83 
T 1.31  0.40  0.28  0.41  1.37  0.26 (1.50)  2.99 (2.47)  12.17 
A 1.98  0.03  0.00 (0.17)  0.00 (0.0044)  0.00  3.19 (3.50)  9.78 
CRM 2.64 (0.04)  0.00 (0.21)  0.00 (0.05)  0.00  6.33 (5.28)  16.84 
JPM 1.46 (0.10)  0.00 (0.29)  0.00 (0.06)  0.00  2.98 (3.00)  10.78 
MRK 1.08  0.30  0.34  0.40  0.99  0.28 (1.26)  2.16 (1.65)  7.61 
XOM 1.96  0.31  0.10  0.14  2.96  0.13 (1.71)  3.03 (3.96)  11.86 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immunoprecise Antibodies without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Investing Immunoprecise Antibodies

You need to understand the risk of investing before taking a position in Immunoprecise Antibodies. The danger of trading Immunoprecise Antibodies is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Immunoprecise Antibodies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Immunoprecise Antibodies. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Immunoprecise Antibodies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
90.4 M
Quarterly Revenue Growth YOY
0.066
Return On Assets
-0.19
Return On Equity
-0.43
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.